There is a newer version of the record available.

Published 2026 | Version 1
Poster Open

Optimization and Validation of a Biochemical FRET Assay for the Exonuclease Activity of SARS COV-2 NSP14-NSP10 Complex

Authors/Creators

  • 1. ROR icon University of Pavia
  • 2. ROR icon Wrocław University of Environmental and Life Sciences
  • 3. ROR icon University of Cagliari
  • 4. Department of Life and Environmental Sciences, University of Cagliari, 09042, Monserrato, Italy

Description

SARS-CoV-2, the virus responsible for COVID-19, has one of the longest RNA genomes among RNA viruses. To correct replication errors, it uses a unique proofreading mechanism involving the nsp14 protein, which has 3'-5' exonuclease activity, assisted by the cofactor nsp10. Currently, there are no drugs targeting this function. To support antiviral research, nsp14 and nsp10 were expressed and purified in E. Coli cells, and a FRET-based biochemical assay was developed to study their exonuclease activity, as previously mentioned in the literature. This system lays the groundwork for identifying future inhibitors of the nsp14-nsp10 complex.

Abstract

POSTER ABSTRACT

Files

15963941.pdf

Files (759.7 kB)

Name Size Download all
md5:d4b8eec12cfdd8d426bfb7c2be7ed07e
750.7 kB Preview Download
md5:f7617ff1dfc1547315882107b5628d74
9.0 kB Preview Download

Additional details

Related works

Is described by
Other: https://sandbox.posters.science/discover/33782 (URL)

Funding

FUNDER
FUNDER
AWARD TITLE 488209384

Dates

Submitted
2026-07-29
Submitted to Zenodo through Posters.science
Other
2026-07-30
Poster presentation date